Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
MedTech startup Carcinotech raises $5.3m to develop 3D printed micro-tumor technology
Life Sciences Times
-
January 31, 2024
0
Venture Capital
Onera raises over €30M in Series C funding
Life Sciences Times
-
January 16, 2024
0
Venture Capital
Rune Labs Unveils $12 Million Strategic Round to Accelerate Adoption of Novel Parkinson’s Technologies
Life Sciences Times
-
January 11, 2024
0
Venture Capital
PharmAlliance Announces Acquisition of Monitor for Hire
Life Sciences Times
-
January 11, 2024
0
Venture Capital
Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential
Life Sciences Times
-
January 10, 2024
0
Venture Capital
Novvia Group Acquires JWJ Packaging
Life Sciences Times
-
December 21, 2023
0
Venture Capital
Lyndra Therapeutics Raises $101 Million in Series E Funding
Life Sciences Times
-
December 21, 2023
0
Venture Capital
Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the Clinic
Life Sciences Times
-
December 20, 2023
0
Venture Capital
Lassen Therapeutics Announces Closing of Oversubscribed $85 Million Series B Financing and Announces First Patient Dosed in the Phase 1 Trial Evaluating LASN01 in...
Life Sciences Times
-
December 19, 2023
0
Venture Capital
Molina Healthcare Amends Terms for Acquisition of Bright HealthCare’s California Medicare Business
Life Sciences Times
-
December 18, 2023
0
Venture Capital
LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform
Life Sciences Times
-
December 18, 2023
0
Biotech
Amide Technologies Announces Complex Peptide Manufacturing Platform, Raises $16.5M to Expedite Frontier Drug Discovery
Life Sciences Times
-
December 14, 2023
0
1
...
35
36
37
...
115
Page 36 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026